Hering David 4

4 · Invivyd, Inc. · Filed Dec 16, 2022

Form 4

Period: 2022-12-14

Chief Operating Officer

Transactions

Award
Stock Option (Right to Buy)
2022-12-14+900,000→ 900,000 total
Exercise: $1.73Exp: 2032-12-13→ Common Stock (900,000 underlying)
Award
Stock Option (Right to Buy)
2022-12-14+700,000→ 700,000 total
Exercise: $1.73Exp: 2032-12-13→ Common Stock (700,000 underlying)

Footnotes (3)

[F1]This option grant is made pursuant to the Reporting Person's achievement of certain performance goals as contemplated by Section 2(g) of that certain Employment Agreement, dated July 5, 2022, between the Reporting Person and the Issuer, as previously disclosed in a Current Report on Form 8-K filed by the Issuer on July 5, 2022.
[F2]This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of December 14, 2022, subject to the Reporting Person's continuous service as of each vesting date.
[F3]This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of December 14, 2022, subject to the Reporting Person's continuous service as of each vesting date.

Documents

1 file